TRAVERE THERAPEUTICSCS INC
TRAVERE THERAPEUTICSCS INC
Action · US89422G1076 · TVTX · A2QHYP (XNAS)
Aperçu Indicateurs financiers
15,32 USD
4,08 % 0,60 USD
NASDAQ (XNAS) · Cours et graphiques actuels sur MoneyPeak
06.06.2025 20:00

Cours actuels de TRAVERE THERAPEUTICSCS INC

BourseTickerDeviseDernier échangeCoursVariation journalière
XNAS: NASDAQ
NASDAQ
TVTX
USD
06.06.2025 20:00
15,32 USD
14,72 USD
+4,08 %

Performance

Jour Semaine Mois 3 mois 6 mois 1 an 5 ans
0,00 % 2,00 % -23,21 % -19,11 % -20,29 % 111,89 % -5,84 %

Profil de l'entreprise pour TRAVERE THERAPEUTICSCS INC Action

Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development, commercialization, and delivering of therapies for the treatment of rare diseases. Its marketed products include Chenodal, a synthetic oral form of chenodeoxycholic acid for the treatment of radiolucent stones in gallbladders; Cholbam, a cholic acid capsule to treat pediatric and adult patients with bile acid synthesis disorders due to single enzyme defects, as well as for adjunctive treatment of patients with peroxisomal disorders; and Thiola and Thiola EC, a tiopronin tablet for the treatment of homozygous cystinuria. The company's product candidates also consist of Sparsentan, which is in Phase III clinical trial for the treatment of focal segmental glomerulosclerosis and immunoglobulin A nephropathy; and TVT-058, a novel investigational human enzyme replacement candidate, which is in Phase I/II clinical trials for the treatment of classical homocystinuria. It has a cooperative research and development agreement with National Institutes of Health's National Center for Advancing Translational Sciences and patient advocacy organizations, CDG Care, and Alagille Syndrome Alliance for the identification of potential small molecule therapeutics for NGLY1 deficiency and Alagille syndrome. The company was formerly known as Retrophin, Inc. and changed its name to Travere Therapeutics, Inc. in November 2020. Travere Therapeutics, Inc. was incorporated in 2008 and is headquartered in San Diego, California.

Fonds investis

Les fonds suivants ont investi dans : TRAVERE THERAPEUTICSCS INC investi :

Fonds
iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)
Vol. en millions
43,83
Part (%)
0,10 %

Données de l'entreprise

Nom TRAVERE THERAPEUTICSCS INC
Société Travere Therapeutics, Inc.
Symbole TVTX
Site web https://www.travere.com
Marché d'origine XNAS NASDAQ
WKN A2QHYP
ISIN US89422G1076
Type de titre Action
Secteur Healthcare
Industrie Biotechnology
PDG Dr. Eric M. Dube Ph.D.
Capitalisation boursière 1 Mrd.
Pays États-Unis d'Amérique
Devise USD
Employés 0,4 T
Adresse 3611 Valley Centre Drive, 92130 San Diego
Date d'introduction en bourse 2012-11-08

Changements d'identifiant

Date De À
19.11.2020 RTRX TVTX

Symboles boursiers

Nom Symbole
NASDAQ TVTX

Autres actions

Les investisseurs qui détiennent TRAVERE THERAPEUTICSCS INC ont également les actions suivantes dans leur portefeuille :
AMGEN INC
AMGEN INC Action
AUTODESK INC
AUTODESK INC Action
BIOGEN INC
BIOGEN INC Action
CISCO SYSTEMS INC
CISCO SYSTEMS INC Action
COSTCO WHOLESALE CORP
COSTCO WHOLESALE CORP Action
DZ BANK CLN E.9239
DZ BANK CLN E.9239 Obligation
EBAY INC
EBAY INC Action
ETC GROUP CORE BITCOIN OE
ETC GROUP CORE BITCOIN OE ETN
INTEL CORP
INTEL CORP Action
KENTUCKY FIRST FEDERAL BANCORP
KENTUCKY FIRST FEDERAL BANCORP Action
MICROSOFT CORP
MICROSOFT CORP Action
O'REILLY AUTOMOTIVE INC
O'REILLY AUTOMOTIVE INC Action
STRATIS
STRATIS Crypto
WALGREENS BOOTS ALLIANCE INC
WALGREENS BOOTS ALLIANCE INC Action
La plateforme financière MoneyPeak suit et analyse les investissements et les portefeuilles. Du dépôt de titres à l'achat de crypto.
Utile, simple et gratuit. Actions, ETF, ETC, ETN, indices, fonds, obligations, certificats, devises, options, droits de souscription.
Mentions légales Protection des données Blog Communauté Retour d'information Changelog
Im App Store herunterladen Bei Google Play herunterladen
Tous droits réservés © LCP GmbH 2025